Exosome-MSC Intravenous injection / Dermama Biotech Lab 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Exosome-MSC Intravenous injection / Dermama Biotech Lab
EXOMSC-COV19, NCT05216562: Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients

Recruiting
2/3
60
RoW
Exosome-MSC Intravenous injection, Dermama Exosome-MSC, Placebo Intravenous Injection, Placebo, COVID-19 Standard Treatment, Drugs accepted as cures for COVID-19
Dermama Bioteknologi Laboratorium, Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia
SARS-CoV2 Infection
06/22
12/22

Download Options